XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
Common Stock
Additional Paid-In Capital
Total Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 816 $ 82,377,488 $ (54,054,774) $ 28,323,530
Balance, shares at Dec. 31, 2022 8,163,923      
Changes in Stockholders' (Deficit) Equity        
Exercise of stock options $ 6 7,380   7,386
Exercise of stock options, shares 52,755      
Stock-based compensation expense   1,542,338   1,542,338
Net loss     (9,737,181) (9,737,181)
Balance at Mar. 31, 2023 $ 822 83,927,206 (63,791,955) 20,136,073
Balance, shares at Mar. 31, 2023 8,216,678      
Balance at Dec. 31, 2023 $ 1,052 102,507,189 (110,259,087) (7,750,846)
Balance, shares at Dec. 31, 2023 10,519,933      
Changes in Stockholders' (Deficit) Equity        
Exercise of common stock warrants $ 6 1,223,994   1,224,000
Exercise of common stock warrants, shares 60,000      
Issuance of common stock, net of issuance costs $ 43 3,874,957   3,875,000
Issuance of common stock, net of issuance costs, shares 431,366      
Stock-based compensation expense   364,765   364,765
Net loss     (1,066,947) (1,066,947)
Balance at Mar. 31, 2024 $ 1,101 $ 107,970,905 $ (111,326,034) $ (3,354,028)
Balance, shares at Mar. 31, 2024 11,011,299